• 1. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 2. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 3. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849
• 4. Evolution of important glucosinolates in three common Brassica vegetables during their processing into vegetable powder and in vitro gastric digestion
  Nan Fu,Naphaporn Chiewchan,Xiao Dong Chen Food Funct., 2020,11, 211-220
• 5. Excellent kinetics of single-phase Gd-doped ceria fuel electrodes in solid oxide cells?
  Andreas Nenning,Manuel Holzmann,Jürgen Fleig,Alexander K. Opitz Mater. Adv., 2021,2, 5422-5431

Introduction to Tert-butyl N-[(3S)-3-methylpyrrolidin-3-yl]carbamate (CAS No. 927652-04-8)

Tert-butyl N-[(3S)-3-methylpyrrolidin-3-yl]carbamate, a compound with the chemical formula C₁₁H₁₉N₂O₂, is a significant molecule in the field of pharmaceutical chemistry. This compound is characterized by its unique structural features, which include a tert-butyl group and a (3S)-3-methylpyrrolidin-3-yl moiety. The CAS number 927652-04-8 provides a unique identifier for this substance, facilitating its recognition and study in various scientific contexts.

The tert-butyl group is a branched alkyl group that enhances the lipophilicity of the molecule, making it more soluble in organic solvents. This property is particularly valuable in pharmaceutical formulations where solubility plays a crucial role in drug delivery and bioavailability. On the other hand, the (3S)-3-methylpyrrolidin-3-yl moiety contributes to the chirality of the compound, which is essential for many biological activities. Chiral drugs often exhibit different pharmacological properties depending on their stereochemistry, making the precise control of stereochemistry during synthesis critical.

In recent years, there has been growing interest in the development of novel carbamate-based compounds due to their diverse biological activities. Carbamates are known for their ability to act as intermediates in the synthesis of various pharmacologically active agents. The compound Tert-butyl N-[(3S)-3-methylpyrrolidin-3-yl]carbamate has garnered attention for its potential applications in the treatment of neurological disorders. Studies have shown that carbamate derivatives can interact with specific enzymes and receptors, modulating neural activity and potentially offering therapeutic benefits.

One of the most compelling aspects of Tert-butyl N-[(3S)-3-methylpyrrolidin-3-yl]carbamate is its structural similarity to known bioactive molecules. This similarity suggests that it may possess similar pharmacological properties, although further research is needed to fully elucidate its mechanism of action. Researchers have been exploring its potential as a precursor for more complex drug molecules, leveraging its unique structural features to design new compounds with enhanced efficacy and reduced side effects.

The synthesis of Tert-butyl N-[(3S)-3-methylpyrrolidin-3-yl]carbamate involves multi-step organic reactions, requiring precise control over reaction conditions to ensure high yield and purity. The use of chiral auxiliaries or catalysts is often necessary to achieve the desired stereochemical outcome. Advances in synthetic methodologies have made it possible to produce this compound with increasing efficiency, paving the way for larger-scale applications in drug development.

Recent studies have also highlighted the importance of understanding the metabolic pathways involving Tert-butyl N-[(3S)-3-methylpyrrolidin-3-yl]carbamate. Metabolism plays a critical role in determining the bioavailability and toxicity of a drug, and identifying key metabolic pathways can help optimize drug design. Researchers are using computational modeling and experimental techniques to predict how this compound might be metabolized in vivo, providing valuable insights into its potential therapeutic applications.

The pharmaceutical industry continues to invest heavily in research aimed at discovering new therapeutic agents. Tert-butyl N-[(3S)-3-methylpyrrolidin-3-yl]carbamate represents an exciting example of how structural modifications can lead to novel bioactive compounds. By understanding its properties and potential applications, scientists can develop new drugs that address unmet medical needs more effectively.

In conclusion, Tert-butyl N-[(3S)-3-methylpyrrolidin-3-yl]carbamate (CAS No. 927652-04-8) is a promising compound with significant potential in pharmaceutical research. Its unique structural features, combined with its biological activity, make it an attractive candidate for further investigation. As our understanding of its properties and mechanisms continues to grow, so too will its potential applications in medicine.

• 219323-14-5(tert-butyl N-[(3S)-4,4-dimethylpyrrolidin-3-yl]carbamate)
• 219323-15-6(tert-butyl N-[(3R)-4,4-dimethylpyrrolidin-3-yl]carbamate)
• 167888-15-5(Tert-butyl N-[(3R)-3-methylpyrrolidin-3-yl]carbamate)
• 167888-17-7(Carbamic acid,(3-methyl-3-pyrrolidinyl)-, 1,1-dimethylethyl ester, (-)- (9CI))
• 171906-65-3(tert-butyl N-{3-azabicyclo[3.2.0]heptan-1-yl}carbamate)
• 147459-52-7(tert-butyl N-(3-methylpyrrolidin-3-yl)carbamate)
• 107610-73-1(tert-butyl N-[trans-4-methylpyrrolidin-3-yl]carbamate)
• 319906-53-1(tert-butyl N-[(3S,4R)-4-methylpyrrolidin-3-yl]carbamate)
• 1334481-84-3(tert-butyl N-[(3R,4S)-4-methylpyrrolidin-3-yl]carbamate)
• 107610-69-5(tert-butyl N-[cis-4-methylpyrrolidin-3-yl]carbamate)